An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...
An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...
In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...
Announced strategic financing with Arena Investors, providing access to up to $59.0 million USD in gross proceeds to Incannex Announced positive ...
Hosted on MSN6d
Synthetic THC May Calm Agitation in Alzheimer's PatientsA synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.
Alaska State Trooper investigators report that they executed a search warrant at a Seward residence on Thursday following an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback